carbamazepine has been researched along with Anxiety in 32 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study prospectively examined whether continued add-on treatment with oxcarbazepine (OXC) is associated with quantitative improvement in mood and anxiety symptoms in adult patients with partial epilepsy." | 9.12 | Oxcarbazepine improves mood in patients with epilepsy. ( Bria, P; Della Marca, G; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Mazza, S; Pozzi, G, 2007) |
| "Carbamazepine (CBZ) is one of the widely distributed pharmaceutical residues in aquatic environments, yet few researches have addressed its chronic effect on the anxiety of fish, and the mechanisms possibly involved remained elusive." | 8.31 | Chronic exposure to environmentally relevant concentrations of carbamazepine interferes with anxiety response of adult female zebrafish through GABA /5-HT pathway and HPI axis. ( Chen, QL; Li, YW; Liu, ZH; Shen, YJ; Tan, ML; Xie, CT, 2023) |
| "An open pilot study to evaluate the effect of pregabalin (PGB) as add-on therapy on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy (BTRE)." | 7.78 | Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study. ( Carapella, CM; Dinapoli, L; Fabi, A; Maschio, M; Pace, A; Pompili, A; Sperati, F; Vidiri, A, 2012) |
| "This study prospectively examined whether continued add-on treatment with oxcarbazepine (OXC) is associated with quantitative improvement in mood and anxiety symptoms in adult patients with partial epilepsy." | 5.12 | Oxcarbazepine improves mood in patients with epilepsy. ( Bria, P; Della Marca, G; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Mazza, S; Pozzi, G, 2007) |
| "Carbamazepine (CBZ) is one of the widely distributed pharmaceutical residues in aquatic environments, yet few researches have addressed its chronic effect on the anxiety of fish, and the mechanisms possibly involved remained elusive." | 4.31 | Chronic exposure to environmentally relevant concentrations of carbamazepine interferes with anxiety response of adult female zebrafish through GABA /5-HT pathway and HPI axis. ( Chen, QL; Li, YW; Liu, ZH; Shen, YJ; Tan, ML; Xie, CT, 2023) |
| "An open pilot study to evaluate the effect of pregabalin (PGB) as add-on therapy on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy (BTRE)." | 3.78 | Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study. ( Carapella, CM; Dinapoli, L; Fabi, A; Maschio, M; Pace, A; Pompili, A; Sperati, F; Vidiri, A, 2012) |
| "The successful use of antiepileptic drugs to treat a wide range of nonepileptic disorders led us to evaluate the potential efficacy of carbamazepine (CBZ) in anxiety disorders." | 3.75 | Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test. ( Bina, P; Rezvanfard, M; Zarrindast, MR, 2009) |
| "Medications targeting insomnia yielded mixed results." | 2.58 | Review: Adjunctive pharmacologic approaches for benzodiazepine tapers. ( Bogunovic, O; McHugh, RK; Tretyak, V; Weiss, RD; Welsh, JW, 2018) |
| "Levetiracetam was independently associated with anger/aggression, nervousness/agitation, upset stomach, depression, and sleep disturbance; lamotrigine with nervousness/agitation, upset stomach, and difficulty concentrating; and valproic acid with upset stomach and shaky hands." | 1.43 | Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study. ( Fidzinski, P; Gaus, V; Holtkamp, M; Kowski, AB; Losch, F; Weissinger, F, 2016) |
| " LGI1 gene dosage was performed by real-time quantitative PCR (qPCR)." | 1.38 | LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. ( Barozzi, C; Cubeddu, T; de Falco, A; de Falco, FA; Errichiello, L; Fanciulli, M; Michelucci, R; Nobile, C; Rampazzo, A; Rigon, L; Santulli, L; Striano, P; Striano, S; Tomasi, L; Uzzau, S, 2012) |
| "To explore the time course of treatment-emergent adverse events (AEs) during topiramate (TPM) adjunctive therapy." | 1.33 | Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine. ( Majkowski, J; Neto, W; Van Oene, J; Wapenaar, R, 2005) |
| ") was antagonized by the chronic administration of lorazepam as well as sodium valproate, a GABA agonist." | 1.28 | The anxiogenic-like effects of pentylenetetrazole in mice treated chronically with carbamazepine or valproate. ( de Angelis, L, 1992) |
| "Treatment with carbamazepine attenuated (P less than 0." | 1.28 | Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepine. ( Browne, TR; Galpern, WR; Greenblatt, DJ; Miller, LG; Shader, RI; Szabo, GK, 1991) |
| "Fundamental withdrawal symptoms (like hypersensitivity to sensory stimuli, abnormal perception of movement, depersonalisation or derealisation) were also less severe in the group treated with CBZ compared with the group not receiving that treatment." | 1.28 | Treatment of benzodiazepine withdrawal symptoms with carbamazepine. ( Apelt, S; Bronisch, T; Emrich, HM; Garcia-Borreguero, D; Yassouridis, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.63) | 18.7374 |
| 1990's | 8 (25.00) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 9 (28.13) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, CT | 1 |
| Tan, ML | 1 |
| Li, YW | 1 |
| Chen, QL | 1 |
| Shen, YJ | 1 |
| Liu, ZH | 1 |
| Schmitz, B | 1 |
| Dimova, S | 1 |
| Zhang, Y | 1 |
| Chellun, D | 1 |
| De Backer, M | 1 |
| Gasalla, T | 1 |
| Hamed, SA | 1 |
| Attiah, FA | 1 |
| Gabra, RH | 1 |
| Sherif, TK | 1 |
| Häfele, CA | 1 |
| Freitas, MP | 1 |
| Gervini, BL | 1 |
| de Carvalho, RM | 1 |
| Rombaldi, AJ | 1 |
| Welsh, JW | 1 |
| Tretyak, V | 1 |
| McHugh, RK | 1 |
| Weiss, RD | 1 |
| Bogunovic, O | 1 |
| Silva, EF | 1 |
| Silva, AI | 1 |
| Asth, L | 1 |
| Souza, LS | 1 |
| Zaveri, NT | 1 |
| Guerrini, R | 1 |
| Calo', G | 1 |
| Ruzza, C | 1 |
| Gavioli, EC | 1 |
| Barker-Haliski, ML | 1 |
| Dahle, EJ | 1 |
| Heck, TD | 1 |
| Pruess, TH | 1 |
| Vanegas, F | 1 |
| Wilcox, KS | 1 |
| White, HS | 1 |
| Kowski, AB | 1 |
| Weissinger, F | 1 |
| Gaus, V | 1 |
| Fidzinski, P | 1 |
| Losch, F | 1 |
| Holtkamp, M | 1 |
| Rezvanfard, M | 1 |
| Zarrindast, MR | 1 |
| Bina, P | 1 |
| Balogh, A | 1 |
| Szentesi, A | 1 |
| Jánosi, I | 1 |
| Vadász, D | 1 |
| Klivényi, P | 1 |
| Vécsei, L | 1 |
| Fanciulli, M | 1 |
| Santulli, L | 1 |
| Errichiello, L | 1 |
| Barozzi, C | 1 |
| Tomasi, L | 1 |
| Rigon, L | 1 |
| Cubeddu, T | 1 |
| de Falco, A | 1 |
| Rampazzo, A | 1 |
| Michelucci, R | 1 |
| Uzzau, S | 1 |
| Striano, S | 1 |
| de Falco, FA | 1 |
| Striano, P | 1 |
| Nobile, C | 1 |
| Maschio, M | 1 |
| Dinapoli, L | 1 |
| Sperati, F | 1 |
| Pace, A | 1 |
| Fabi, A | 1 |
| Vidiri, A | 1 |
| Pompili, A | 1 |
| Carapella, CM | 1 |
| Kaufman, KR | 1 |
| Gerner, R | 1 |
| Majkowski, J | 1 |
| Neto, W | 1 |
| Wapenaar, R | 1 |
| Van Oene, J | 1 |
| Tölle, T | 1 |
| Dukes, E | 1 |
| Sadosky, A | 1 |
| Mazza, M | 1 |
| Della Marca, G | 1 |
| Di Nicola, M | 1 |
| Martinotti, G | 1 |
| Pozzi, G | 1 |
| Janiri, L | 1 |
| Bria, P | 1 |
| Mazza, S | 1 |
| Borromei, A | 1 |
| Bertocchi, S | 1 |
| Kranzler, HR | 2 |
| Bauer, LO | 2 |
| Hersh, D | 1 |
| Klinghoffer, V | 1 |
| Gillen, RW | 1 |
| Burleson, JA | 1 |
| Samarel, D | 1 |
| Morrison, DJ | 1 |
| Paetzold, W | 1 |
| Eronat, V | 1 |
| Seifert, J | 1 |
| Holze, I | 1 |
| Emrich, HM | 2 |
| Schneider, U | 1 |
| Malcolm, R | 1 |
| Myrick, H | 1 |
| Roberts, J | 1 |
| Wang, W | 1 |
| Anton, RF | 1 |
| de Angelis, L | 1 |
| Kopchia, KL | 1 |
| Altman, HJ | 1 |
| Commissaris, RL | 1 |
| Galpern, WR | 1 |
| Miller, LG | 1 |
| Greenblatt, DJ | 1 |
| Szabo, GK | 1 |
| Browne, TR | 1 |
| Shader, RI | 1 |
| Garcia-Borreguero, D | 1 |
| Bronisch, T | 1 |
| Apelt, S | 1 |
| Yassouridis, A | 1 |
| Altshuler, LL | 1 |
| Devinsky, O | 1 |
| Post, RM | 1 |
| Theodore, W | 1 |
| Almeida, RN | 1 |
| Leite, JR | 2 |
| Zangrossi Júnior, H | 1 |
| Graeff, FG | 1 |
| Risse, SC | 1 |
| Barnes, R | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Babington, RG | 1 |
| Horovitz, ZP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Monitoring of Seizures, EEG and Serum Antiepileptic Drug Concentrations in Patients With Uncontrolled Epilepsy[NCT00001149] | 900 participants | Observational | 1975-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for carbamazepine and Anxiety
| Article | Year |
|---|---|
Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
Topics: Anti-Anxiety Agents; Anticonvulsants; Anxiety; Benzodiazepines; Carbamazepine; Humans; Hypnotics and | 2018 |
Pharmacologic treatment of agitation associated with dementia.
Topics: Affective Symptoms; Aged; Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; | 1986 |
6 trials available for carbamazepine and Anxiety
| Article | Year |
|---|---|
Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Delayed-Action Preparations; Depression; Doubl | 2020 |
Oxcarbazepine improves mood in patients with epilepsy.
Topics: Adult; Analysis of Variance; Anticonvulsants; Antidepressive Agents; Anxiety; Carbamazepine; Case-Co | 2007 |
Carbamazepine treatment of cocaine dependence: a placebo-controlled trial.
Topics: Adolescent; Adult; Alcoholism; Anticonvulsants; Anxiety; Carbamazepine; Cocaine; Comorbidity; Depres | 1995 |
[Detoxification of poly-substance abusers with buprenorphine. Effects on affect, anxiety, and withdrawal symptoms].
Topics: Adult; Affect; Analgesics, Non-Narcotic; Analysis of Variance; Anti-Anxiety Agents; Anxiety; Bupreno | 2000 |
The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification.
Topics: Adult; Affect; Alcoholism; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Carbamazepine; Double-Blin | 2002 |
Studies with new drugs in the treatment of convulsive disorders.
Topics: Adult; Aggression; Anticonvulsants; Anxiety; Carbamazepine; Clinical Trials as Topic; Diazepam; Dibe | 1968 |
24 other studies available for carbamazepine and Anxiety
| Article | Year |
|---|---|
Chronic exposure to environmentally relevant concentrations of carbamazepine interferes with anxiety response of adult female zebrafish through GABA /5-HT pathway and HPI axis.
Topics: Animals; Anxiety; Carbamazepine; Female; gamma-Aminobutyric Acid; Hydrocortisone; Serotonin; Water P | 2023 |
Sexual functions in women with focal epilepsy: Relationship to demographic, clinical, hormonal and psychological variables.
Topics: Adult; Anticonvulsants; Anxiety; Carbamazepine; Depression; Egypt; Epilepsy, Frontal Lobe; Epilepsy, | 2020 |
Who are the individuals diagnosed with epilepsy using the Public Health System in the city of Pelotas, southern Brazil?
Topics: Adolescent; Adult; Aged; Anticonvulsants; Anxiety; Brazil; Carbamazepine; Child; Cross-Sectional Stu | 2018 |
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test.
Topics: Aggression; Agonistic Behavior; Animals; Anxiety; Bipolar Disorder; Carbamazepine; Cycloheptanes; De | 2019 |
Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model
Topics: Animals; Anticonvulsants; Anxiety; Behavior, Animal; Carbamazepine; Cardiovirus Infections; Comorbid | 2015 |
Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Depression; Drug-Related Side Effects and Adve | 2016 |
Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Carbamazepine; Disease Models, Animal; GABA Agonists; GABA An | 2009 |
[Multicenter observational study of the effect of oxcarbazepine on the general well-being of adults with partial epilepsy].
Topics: Adult; Affect; Aged; Anticonvulsants; Anxiety; Carbamazepine; Epilepsies, Partial; Female; Happiness | 2010 |
[Paroxysmal kinesigenic dyskinesia].
Topics: Anticonvulsants; Anxiety; Carbamazepine; Chorea; Humans; Male; Quality of Life; Social Isolation; Yo | 2011 |
LGI1 microdeletion in autosomal dominant lateral temporal epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Anxiety; Carbamazepine; Depressive Disorder, Major; Electroencep | 2012 |
Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Benzodiazepines; Brain Neoplasms; Carbamazepine; Clobazam; Dr | 2012 |
Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: case analysis and literature review.
Topics: Adult; Anticonvulsants; Anxiety; Carbamazepine; Comorbidity; Drug Therapy, Combination; Follow-Up St | 2003 |
Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Double-Blind Method; Drug Therapy, | 2005 |
Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries.
Topics: Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Antidepressive Agents; Anxiety; Carbamazep | 2006 |
[Rational medical and surgical therapy of essential facial hemispasm. Experiences in 21 cases].
Topics: Adult; Aged; Angiography; Anxiety; Carbamazepine; Electroencephalography; Electromyography; Facial N | 1984 |
Neuropsychologic findings in cocaine-dependent outpatients.
Topics: Adult; Analgesics, Non-Narcotic; Anxiety; Carbamazepine; Cocaine-Related Disorders; Cognition; Human | 1998 |
The anxiogenic-like effects of pentylenetetrazole in mice treated chronically with carbamazepine or valproate.
Topics: Animals; Anxiety; Behavior, Animal; Carbamazepine; Female; Lorazepam; Mice; Pentylenetetrazole; Valp | 1992 |
Effects of lesions of the central nucleus of the amygdala on anxiety-like behaviors in the rat.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Carbamazepine; Chlordiazepoxide; Conditioning, Operant | 1992 |
Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepine.
Topics: Alprazolam; Animals; Anxiety; Carbamazepine; Cerebral Cortex; Disease Models, Animal; Drug Administr | 1991 |
Treatment of benzodiazepine withdrawal symptoms with carbamazepine.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Arousal; Carbamazepine; Crisis Intervention; Depression; Diazep | 1991 |
Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms.
Topics: Adult; Analysis of Variance; Anxiety; Carbamazepine; Depression; Epilepsy, Temporal Lobe; Female; Fu | 1990 |
Effects of acute or chronic carbamazepine on experimentally-induced conflict in the rat.
Topics: Animals; Anxiety; Behavior, Animal; Carbamazepine; Conditioning, Operant; Conflict, Psychological; D | 1990 |
Anxiolytic effect of carbamazepine measured in the elevated plus-maze.
Topics: Animal Testing Alternatives; Animals; Anxiety; Carbamazepine; Exploratory Behavior; Male; Rats; Rats | 1989 |
Neuropharmacology of SQ 10,996, a compound with several therapeutic indications.
Topics: Amides; Animals; Anticonvulsants; Antidepressive Agents; Anxiety; Behavior, Animal; Carbamazepine; C | 1973 |